Discover
IBO
Impact BioMedical Inc.
0.43
1 x 0.42
1 x 0.44
bid
ask
-
0.01
1.26%
12:23 PM
timesize
| Ytd | -14.85% | |
| 1y | -23.08% |
0.43
day range
0.43
0.37
52 week range
0.83
| Open | 0.43 | Prev Close | 0.44 | Low | 0.43 | High | 0.43 | Mkt Cap | 46.36M |
| Vol | 74.40K | Avg Vol | 55.15K | EPS | -1.74 | P/E | -0.25 | Forward P/E | N/A |
| Beta | 2.73 | Short Ratio | 0.06 | Inst. Own | 1.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.49 | 200-d Avg | 0.52 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 3.00K | ||
| Revenues (USD) | 3.00K | ||
| Cost of Revenue | 1000 | ||
| Gross Profit | 2.00K | ||
| Operating Expenses | 704.00K | ||
| Research and Development Expense | 76.00K | ||
| Selling, General and Administrative Expense | 185.00K | ||
| Operating Income | -702.00K | ||
| Net Income | -699.00K | ||
| Net Income Common Stock | -699.00K | ||
| Net Income Common Stock (USD) | -699.00K | ||
| Consolidated Income | -700.00K | ||
| Net Income to Non-Controlling Interests | -1000 | ||
| Earnings per Basic Share | -0.01 | ||
| Earnings per Basic Share (USD) | -0.01 | ||
| Earnings per Diluted Share | -0.01 | ||
| Earning Before Interest & Taxes (EBIT) | -699.00K | ||
| Earning Before Interest & Taxes (USD) | -699.00K | ||
| Weighted Average Shares | 107.82M | ||
| Weighted Average Shares Diluted | 107.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 10.00K | ||
| Cash and Equivalents (USD) | 10.00K | ||
| Investments | 197.00K | ||
| Investments Current | 197.00K | ||
| Current Assets | 320.00K | ||
| Total Assets | 16.75M | ||
| Current Liabilities | 2.05M | ||
| Total Liabilities | 2.73M | ||
| Accumulated Retained Earnings (Deficit) | -52.49M | ||
| Shareholders Equity | 10.77M | ||
| Shareholders Equity (USD) | 10.77M | ||
| Assets Non-Current | 16.43M | ||
| Goodwill and Intangible Assets | 16.43M | ||
| Inventory | 62.00K | ||
| Liabilities Non-Current | 688.00K | ||
| Trade and Non-Trade Payables | 1.80M | ||
| Tax Liabilities | 688.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 284.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.00K | ||
| Net Cash Flow from Investing | 2.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.00K | ||
| Net Cash Flow from Operations | 470.00K | ||